Drew J Adams

19PUBLICATIONS
32CO-AUTHORS
Environmental epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 12, 2026
Mass Spectrometry-Based Screening Reveals Inhibitors of Cholesterol 25-Hydroxylase.

|Apr 21, 2026
Redirecting TRIM21 with TRIMTACs for the targeted degradation of multimeric proteins.

|Mar 27, 2026
A small-molecule stabilizer of the calpastatin-calpain-2 complex restores mitochondrial function and mitigates neurodegeneration.

Di Hu, Xiaoyan Sun, Yutong Shang

|Nov 20, 2025
Nuclear Export Gone Rogue: XPO1's Chromatin Side Hustle Fuels Leukemia.

Drew J Adams

|Jul 16, 2025
Elaboration of molecular glues that target TRIM21 into TRIMTACs that degrade protein aggregates.

Marc A Scemama de Gialluly, Anthony R Allen, Elijah H Hayes

|May 14, 2025
XPO1-Targeting Selective Inhibitors of Transcriptional Activation Suppress Graft-versus-Host Disease.

Yanqiu Shen, Yi Fan Chen, David F Yan

Pageof 4

Frequent Collaborators

4 joint publications

Yuriy Fedorov

4 joint publications

David F Yan

3 joint publications

Amanda N Farrar

3 joint publications

Marc A Scemama de Gialluly